Chartsbank is a comprehensive database containing information on more than 3000 new drugs in development, inclusive of pre-clinical research up to phase IV development

Subscribers view details.


 
Please Select Filter Criteria for the drug pipeline
Drug Pipeline by drug name:
Drug Pipeline by Company:
Drug Pipeline by Disease:

Subscribe

Drug Pipeline by Generic :
Drug Pipeline by Current Status:
Drug Pipeline by ICN:

...31323334353637383940...
CompanyDrug NameStatusIndication Group
Sanofi-aventis Ketek Approved in USAAnti-infectives for systemic use
Sanofi-aventis Ketek Approved in USAAnti-infectives for systemic use
Accera Ketasyn in Phase IINervous system
UCB Pharma Keppra Approved in EU and USANervous system
Amgen Kepivance Approved in EU and USAAlimentary tract & metabolism
BioNumerik Karenitecin in Phase IIAntineoplastic & immunomodulating agents
BioNumerik Karenitecin in Phase IIAntineoplastic & immunomodulating agents
BioNumerik Karenitecin in Phase IIAntineoplastic & immunomodulating agents
BioNumerik Karenitecin in Phase IAntineoplastic & immunomodulating agents
BioNumerik Karenitecin in Phase IAntineoplastic & immunomodulating agents
BioNumerik Karenitecin in Phase IIAntineoplastic & immunomodulating agents
Abbott Laboratories Kaletra Approved in EU and USAAnti-infectives for systemic use
PharmaMar Kahalalide F in Phase IIAntineoplastic & immunomodulating agents
PharmaMar Kahalalide F in Phase IIDermatologicals
IDM Pharma Junovan/Mepact Submitted for approval in USA and EUAntineoplastic & immunomodulating agents
Bristol-Myers Squibb Javlor in Phase IIIAntineoplastic & immunomodulating agents
Bristol-Myers Squibb Javlor in Phase IIIAntineoplastic & immunomodulating agents
Bristol-Myers Squibb Javlor in Phase IIIAntineoplastic & immunomodulating agents
Axcan Pharma ITAX accomplished Phase IIIAlimentary tract & metabolism
Ista Istalol Approved in USASensory organs
...31323334353637383940...




Drug Pipeline Copyright © 2005- 2017 All Rights Reserved.